Clinical Outcomes with Pemetrexed-Based Systemic Therapy in RET-Rearranged Lung Cancers

被引：0
|
作者：
Drilon, Alexander [1 ]
Bergagnini, Isabella [1 ]
Delasos, Lukas [1 ]
Sima, Camelia S. [1 ]
Smith, Roger [1 ]
Somwar, Romel [1 ]
Riely, Gregory J. [1 ]
Kris, Mark G. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
ROS1 ALK KRAS; RET; pemetrexed; rearrangement;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL03.05
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [41] Alectinib shows potent antitumor activity against both ALK- and RET-rearranged non-small cell lung cancers
    Kodama, Tatsushi
    Tsukaguchi, Toshiyuki
    Satoh, Yasuko
    Yoshida, Miyuki
    Watanabe, Yoshiaki
    Kondoh, Osamu
    Sakamoto, Hiroshi
    CANCER RESEARCH, 2015, 75
  • [42] Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study
    Lu, Chang
    Dong, Xiao-Rong
    Zhao, Jun
    Zhang, Xu-Chao
    Chen, Hua-Jun
    Zhou, Qing
    Tu, Hai-Yan
    Ai, Xing-Hao
    Chen, Xiao-Feng
    An, Gai-Li
    Bai, Jun
    Shan, Jin-Lu
    Wang, Yi-Na
    Yang, Shuan-Ying
    Liu, Xiang
    Zhuang, Wu
    Wu, Hui-Ta
    Zhu, Bo
    Xia, Xue-Feng
    Chen, Rong-Rong
    Gu, De-Jian
    Xu, Hua-Min
    Wu, Yi-Long
    Yang, Jin-Ji
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [43] Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study
    Chang Lu
    Xiao-Rong Dong
    Jun Zhao
    Xu-Chao Zhang
    Hua-Jun Chen
    Qing Zhou
    Hai-Yan Tu
    Xing-Hao Ai
    Xiao-Feng Chen
    Gai-Li An
    Jun Bai
    Jin-Lu Shan
    Yi-Na Wang
    Shuan-Ying Yang
    Xiang Liu
    Wu Zhuang
    Hui-Ta Wu
    Bo Zhu
    Xue-Feng Xia
    Rong-Rong Chen
    De-Jian Gu
    Hua-Min Xu
    Yi-Long Wu
    Jin-Ji Yang
    Journal of Hematology & Oncology, 13
  • [44] Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice
    Lee, Jiyun
    Ku, Bo Mi
    Shim, Joon Ho
    La Choi, Yoon
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (05) : 594 - 601
  • [45] Anti-tumor activity and acquired resistance mechanism of dovitinib in RET-rearranged lung adenocarcinoma
    Kang, Chan Woo
    Jang, Kang Won
    Cho, Byoung Chul
    CANCER RESEARCH, 2015, 75
  • [46] Role of ERBB signaling in RET-rearranged lung cancer and contribution of EGFR amplification to cabozantinib resistance.
    Smith, Roger
    Drilon, Alexander E.
    Kunte, Siddharth
    Suzawa, Ken
    Hayashi, Takuo
    Delasos, Lukas
    Tai, Huichun
    Hitchman, Tyler
    Khodos, Inna
    Mattar, Marissa
    Kohsaka, Shinji
    de Stanchina, Elisa
    Lockwood, William
    Ladanyi, Marc
    Somwar, Romel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial
    Felip, Enriqueta
    Smit, Egbert F.
    Molina-Vila, Miguel A.
    Dafni, Urania
    Massuti, Bartomeu
    Berghmans, Thierry
    de Marinis, Filippo
    Passiglia, Francesco
    Dingemans, Anne-Marie C.
    Cobo, Manuel
    Viteri, Santiago
    Britschgi, Christian
    Cuffe, Sinead
    Provencio, Mariano
    Merkelbach-Bruse, Sabine
    Andriakopoulou, Charitini
    Kammler, Roswitha
    Ruepp, Barbara
    Roschitzki-Voser, Heidi
    Peters, Solange
    Wolf, Juergen
    Stahel, Rolf
    LUNG CANCER, 2022, 172 : 94 - 99
  • [48] RET-Rearranged Squamous Cell Carcinoma of the Lung Responding to First-Line Immunotherapy plus Chemotherapy
    Gao, Q.
    Wang, Q.
    Peng, K.
    Zhang, S.
    Zhang, X.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S686 - S686
  • [49] Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
    Kang, Chan Woo
    Jang, Kang Won
    Sohn, Jinyoung
    Kim, Sung-Moo
    Pyo, Kyoung-Ho
    Kim, Hwan
    Yun, Mi Ran
    Kang, Han Na
    Kim, Hye Ryun
    Lim, Sun Min
    Moon, Yong Wha
    Paik, Soonmyung
    Kim, Dae Joon
    Kim, Joo Hang
    Cho, Byoung Chul
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (10) : 2238 - 2248
  • [50] The influence of pemetrexed-based continuous maintenance therapy on survival of locally advanced and metastatic lung adenocarcinoma
    Huang, Yu
    Wang, Ying
    Hu, Dandan
    Chen, Lingjuan
    Zhang, Ruiguang
    Cheng, Shishi
    Wu, Gang
    Dong, Xiaorong
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (20)
12345